Skip to main content
  1. Home

Spring 2026

Task
E&M
Valid for Measure Submission
✔

Advanced Illness and Post-Acute Care Advisory Group Meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings. Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Advanced Illness and Post-Acute Care Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

Advanced Illness and Post-Acute Care Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

Cost and Efficiency Advisory Group Meeting

The purpose of this meeting is for Advisory Group members to raise questions and share perspectives verbally regarding the measures under endorsement review for their respective E&M committee. No voting occurs during these virtual meetings. Rather, Advisory Group members will be asked to review the measures assigned to their respective committee and come to the meeting to ask questions and provide feedback regarding the strengths and limitations of the measures.

Cost and Efficiency Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

E&M Spring 2026 Appeals Committee Meeting

After the Spring 2026 E&M Endorsement meetings, the committee endorsement decisions and associated rationales are posted to the PQM website for three (3) weeks, which represents an appeals period, during which any interested party may request an appeal regarding any E&M committee endorsement decision. If an appeal is eligible, we will convene the Appeals Committee to review the appeal on this date. If no eligible appeals are received, this meeting will be canceled.

ePC-06 Unexpected Complications in Term Newborns

ePC06 is a hospital level performance score reported as the rate per 1,000 full term newborns with no preexisting conditions who had Unexpected Newborn Complications, calculated per calendar year.     

CBE ID
5608e

Excess Days in Acute Care (EDAC) After Hospitalization for Chronic Obstructive Pulmonary Disease (COPD)

The Excess Days in Acute Care (EDAC) After Hospitalization for Chronic Obstructive Pulmonary Disease (COPD) (hereafter “COPD EDAC") measure assesses days spent in acute care within 30 days of discharge from an inpatient hospitalization for COPD. This measure is intended to improve care transition quality for discharged patients hospitalized for COPD by collectively measuring a set of adverse acute care outcomes that can occur post-discharge: emergency department (ED) visits, observation stays, and unplanned readmissions, at any time during the 30 days post-discharge.

CBE ID
5570

Excess Days in Acute Care (EDAC) After Hospitalization for Diabetes

The Excess Days in Acute Care (EDAC) After Hospitalization for Diabetes (hereafter “Diabetes EDAC") measure assesses days spent in acute care within 30 days of discharge from an inpatient hospitalization for diabetes. This measure is intended to improve care transition quality for discharged patients hospitalized for diabetes by collectively measuring a set of adverse acute care outcomes that can occur post-discharge: emergency department (ED) visits, observation stays, and unplanned readmissions at any time during the 30 days post-discharge.

CBE ID
5575